1XZ

Ping An Healthcare and Technology Company Ltd

Healthcare · EUR · F

1XZ

Price

€0.996

-1.68%

Cap

€2.13B

Earnings

30d Trend

-22.1%

1XZ
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

38% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level70
Quality60
Momentum56
Technical39
Fundamentals71

Raw weighted: 55×Macro 0.99 (1%)=54

RISK

70/100
90d Volatility
38.1%High
ATR %
3.0%High daily moves
Max Drawdown (1Y)
-61.3%Volatile

QUALITY

60/100
ROE (avg)
5.6%Weak
Piotroski F-Score
7/9Strong
Margin Stability
CV 13.6%Stable
Accruals
-0.5%Cash earnings
Interest Coverage
80.7xVery comfortable

MOMENTUM

56/100
12-1M Momentum
+44.2%Strong uptrend
6-1M Momentum
-23.5%Negative
1M Return
-14.9%Sharp decline

TECHNICAL

39/100
RSI (14)
21.7Oversold
Price vs SMA200
-37.4%Bearish trend
MACD
-0.01Bearish momentum
Bollinger Band
-2%Near lower band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.646Clean trend

FUNDAMENTALS

71/100
EV/EBIT
1.9Cheap
P/FCF
5.2Cheap
P/S
0.4Cheap
PEG
4.09Overpriced growth

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months58
3-12 months30
1-5+ years62

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate Ping An Healthcare and Technology Company Ltd at 54/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 71/100. I classify this as a growth position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-14.9%

3 MONTHS

-29.1%

12 MONTHS

+29.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. Fundamentals (71) and Quality (60) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is moderate at 38%. I classify this as a growth position — positive trend direction combined with solid fundamentals points to capital appreciation.

growthScore: 54/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.